How do we pick which scleroderma patients are stem cell transplant candidates early enough? “Patient selection is the critical thing in the whole transplant venture” - our patients have damage and aren’t as fit. Jacob van Laar at #EULAR2019 SP0113 @RheumNow https://t.co/cDuAI7iVWk